Company Filing History:
Years Active: 1998
Title: Ei Yamada: Innovating in Chondrocyte Growth
Introduction
Ei Yamada is a distinguished inventor located in Kawasaki, Japan. With a patent to her name, she has made significant contributions to the field of biotechnology, particularly in the study of human chondromodulin-I protein.
Latest Patents
Her most notable patent focuses on a novel human chondromodulin-I protein. This protein has a molecular weight of approximately 26,000 daltons when analyzed through SDS-PAGE. It demonstrates the ability to stimulate the growth of chondrocytes, with or without Fibroblast Growth Factor (FGF). Furthermore, it promotes the differential potency of these cells while inhibiting the growth of vascular endothelial cells. The patent also includes a DNA sequence encoding this protein, along with an expression vector capable of producing recombinant chondromodulin-I protein. The process described in the patent involves culturing a transformant to yield the chondromodulin-I protein and details a pharmaceutical composition that incorporates this protein as an active ingredient.
Career Highlights
Ei Yamada is associated with Mitsubishi Chemical Corporation, where she continues to advance her research and innovations. Her work exemplifies the integration of scientific discovery with practical applications in medicine and biotechnology.
Collaborations
Throughout her career, Yamada has collaborated with esteemed colleagues such as Fujio Suzuki and Yuji Hiraki. These partnerships have allowed her to enhance the scope and impact of her research.
Conclusion
Ei Yamada's contributions to biotechnology, particularly through her innovative patent on human chondromodulin-I protein, highlight her role as a pioneering inventor. Her work not only furthers scientific understanding but also holds potential therapeutic applications in enhancing cartilage repair and related medical treatments.